Barclays
VPHM

Barclays’s VIROPHARMA INC VPHM Stock Holding History

Barclays’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q1 		– Sell
-48,000
Closed -$2.35M – 7961
2013
Q4 		$2.35M Sell
48,000
-369,000
-88% -$16.5M ﹤0.01% 2499
2013
Q3 		$16.3M Buy
417,000
+406,900
+4,029% +$13.3M 0.02% 799
2013
Q2 		$289K Buy
+10,100
New +$266K ﹤0.01% 4824

Barclays's VPHM Position: Q1 2014 in Review

Barclays sold out of VIROPHARMA INC (VPHM) in Q1 2014, closing a stake of 910,864 shares — an estimated $44.6M sold.

Barclays first reported a position in VPHM in Q2 2013 and held it in 3 quarters. The position peaked at $44.6M in Q4 2013. 0 funds tracked by Wall St. Rank hold VPHM as of Q1 2014.

  • Barclays reported no remaining VIROPHARMA INC position as of Q1 2014 after selling out during the quarter.
  • Barclays sold 910,864 VIROPHARMA INC shares in Q1 2014, an estimated $44.6M.
  • Barclays first reported a position in VIROPHARMA INC in Q2 2013 and held it in 3 quarters.
  • Barclays's VIROPHARMA INC position peaked at $44.6M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q1 2014.

Based on Barclays's 13F filing for Q1 2014, filed 15 May 2014.